Reshma Rangwala

CIK 1825322 · EVP & Chief Medical Officer · last filed 2026-05-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$539.9K

Companies

2

Total Filings

18

Lifetime Open-Market Net

-$144.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
KPTI	EVP & Chief Medical Officer	56,829	$9.50	$539.9K	-$144.2K	15	2026-05-15
Aravive, Inc. (ARAV) Delisted	Chief Medical Officer	—	$0.04	—	$0	3	2022-01-25

Recent Filings · Page 2 of 2

18 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-02-29	KPTI	Grant (A)	+198,959	$0	EDGAR
2024-01-25	KPTI	Grant (A)	+14,167	$0	EDGAR
2023-04-24	KPTI	Sell (S)	−6,770	-$27.4K	EDGAR
2023-03-02	KPTI	Grant (A)	+100,000	$0	EDGAR
2022-05-02	KPTI	Grant (A)	+65,000	$0	EDGAR
2022-01-25	Aravive, Inc. (ARAV) Delisted	Grant (A)	—	$0	EDGAR
2021-01-26	Aravive, Inc. (ARAV) Delisted	Grant (A)	—	$0	EDGAR
2020-09-29	Aravive, Inc. (ARAV) Delisted	Grant (A)	—	$0	EDGAR

Showing 11–18 of 18

Prev Page 2 of 2

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.